Point-of-Care Diagnostics: Why Your Hospital Referrals Are Leaving Money on the Table

As of 2026, UnitedHealthcare — the largest Medicare Advantage provider in the country — now requires a PCP referral before any HMO or HMO-POS Medicare Advantage patient can see a cardiologist. Claim denials began May 1, 2026, according to Cardiovascular Business.

Closing cardiac care gaps in internal medicine is no longer optional positioning — it is a policy-mandated clinical responsibility. Internal medicine physicians are now the mandatory first point of contact for cardiac evaluation for millions of Medicare Advantage patients.

The scale of that responsibility is significant. According to the Kaiser Family Foundation, 55% of all eligible Medicare beneficiaries — 35.2 million people — are enrolled in Medicare Advantage plans as of 2026. That is the patient panel sitting in your waiting room right now, with no direct cardiology access unless you authorize it.

The practices that thrive in this environment will be the ones that can evaluate, document, and act on cardiac presentations in the office — not the ones routing patients to a 90-day cardiology wait list. Learn how Perfect Rhythm helps internal medicine practices close cardiac care gaps with in-office diagnostics.

What You Need to Know About Closing Cardiac Care Gaps in Internal Medicine

Internal medicine physicians became mandatory cardiac gatekeepers on January 1, 2026. UnitedHealthcare's new HMO and HMO-POS Medicare Advantage policy now requires a PCP referral before any cardiology visit — with claim denials beginning May 1, 2026. That is not a theoretical policy shift. That is a workflow mandate affecting millions of patients right now.

The clinical stakes for getting this wrong are not abstract. A study published in the Scandinavian Journal of Primary Health Care found that heart failure patients diagnosed in hospitals had a one-year all-cause mortality rate of 42% — compared to 20% for those diagnosed in primary care. The setting of diagnosis is not an administrative detail. It is a survival variable.

The financial pressure is arriving at the same time. CMS now audits all ~550 eligible Medicare Advantage contracts annually for RADV compliance — up from 30–60 per year — and every unsupported HCC code is treated as a 100% overpayment under the 2023 RADV Final Rule, according to Charta Health.

Three forces are now converging on every internal medicine practice with a Medicare Advantage panel:

• Policy mandate: UHC requires PCPs to evaluate cardiac patients before cardiology referral — without in-office diagnostic tools, that evaluation is incomplete
• Clinical urgency: Point-of-care diagnosis produces measurably better survival outcomes than hospital-first pathways
• Audit exposure: An anonymized Medicare Advantage network managing 18,000+ attributed members faced over $1.2 million in estimated annual RADV exposure due to documentation gaps alone, despite strong clinical performance — per an MBW Revenue Cycle Management case study

Inaction is a strategic decision. And right now, it is an expensive one.

Key Strategies and Best Practices

Diagnosing heart failure in your office instead of your patient's ER admission is not a quality-of-life improvement — it is the difference between a 20% and 42% one-year mortality rate. The Scandinavian Journal of Primary Health Care published exactly that comparison: primary care diagnosis versus hospital diagnosis, same disease, radically different survival curves.

Three practice-level shifts close that gap operationally:

• Add non-invasive, in-office cardiac screening. CorVista's FDA-cleared system produces a 99% negative predictive value for CAD — no radiation, no fasting, no referral wait. That is your clinical defense and your documentation anchor when UHC demands a PCP evaluation before approving a cardiology referral.
• Rebuild your HCC coding workflow around V28 logic. RapidClaims AI (2026) confirmed the V28 model eliminates 2,294 diagnosis codes and introduces 268 new ones. Practices still running V24 assumptions are losing RAF revenue and accumulating RADV exposure simultaneously.
• Stop letting pulmonary hypertension hide in plain sight. Fatigue, dyspnea, and chest discomfort read as a dozen other diagnoses first. PharmacoEconomics - Open found delayed PAH diagnosis drives 40–71% more hospitalizations and up to $5,366 higher costs per patient per month — costs your practice does not capture but your patient absolutely absorbs.

As Dr. Charles Bridges, EVP and Chief Scientific Officer at CorVista Health, stated directly: "Both PH and elevated LVEDP, particularly when due to HFpEF, are vastly underrecognized and underdiagnosed — often delaying life-saving treatments."

The practice that screens in-office, codes to V28 standards, and documents every chronic condition with source citations is not just practicing better medicine — it is protecting its Medicare Advantage revenue from every angle CMS has created to claw it back.

Common Mistakes to Avoid

Most internal medicine practices are not failing cardiac patients intentionally. They are failing them systematically — through workflows that treat "refer to cardiology" as a complete clinical response.

These are the patterns that translate directly into missed diagnoses, worse outcomes, and lost revenue.

• Treating symptom overlap as a reason to wait. Shortness of breath, fatigue, and chest discomfort are dismissed as anxiety or deconditioning while pulmonary hypertension silently progresses. According to PharmacoEconomics - Open, delayed PAH diagnosis beyond 12 months is associated with 40–71% more hospitalizations and $3,986–$5,366 higher healthcare costs per patient per month. Waiting is not neutral. It is expensive and dangerous.
• Assuming cardiology referral = cardiac care delivered. Average specialist wait times run 30 to 90 days nationally, according to Cardiovascular Specialists of New England — and up to 120 days in some markets. That is not a care pathway. That is a waiting room with medical liability attached.
• Undertreating confirmed heart failure. The HFSA HF Stats 2025 Report found fewer than one in four eligible patients with HFrEF are receiving quadruple guideline-directed medical therapy. Earlier in-office diagnosis does not help if the treatment protocol does not follow.
• Ignoring HCC coding gaps on cardiac diagnoses. Heart failure and CAD are high-value HCC conditions. Inconsistent documentation does not just create audit risk — it erodes RAF scores and the Medicare Advantage revenue tied to them.

As Biykem Bozkurt, MD, PhD of Baylor College of Medicine and Chair of the HFSA Data in HF Committee stated directly: "The shifts in age distribution, worsening in mortality rates, widening racial and ethnic disparities — should be a wake-up call for clinicians, payers, legislators, funding agencies, and the overall healthcare system."

The mistake is not ignorance. It is inertia.

Practical Next Steps

Cardiology wait times in the US now average 30 to 90 days — and stretch to 120 days in some markets, according to Cardiovascular Specialists of New England. Your Medicare Advantage patients cannot wait four months for a cardiac rule-out. Your practice cannot afford to send them blindly into that queue.

Here is where to act now:

• Audit your UHC Medicare Advantage panel immediately. With UHC HMO/HMO-POS referral mandates in effect and claim denials running since May 1, 2026, every undocumented cardiac evaluation is a denial waiting to happen.
• Map your in-office diagnostic capability against your patient volume. According to a study published in Family Practice (Oxford Academic, 2025), point-of-care evaluation identified Stage B heart failure in 44.9% of at-risk patients — more than double the 19.4% clinical detection rate. If you are not evaluating in-office, you are missing cases.
• Confirm your CPT billing pathways before adding any diagnostic tool. The 2026 AMA CPT update introduced AI-augmented codes for cardiology services, per Unislink's analysis of the AMA update — meaning reimbursement infrastructure now exists for tools like CorVista.
• Run a HCC documentation gap analysis before your next RADV cycle. If your coding workflow has not been updated for V28 logic, your RAF scores are likely understated and your audit exposure is real.

The Lancet Primary Care reported that echocardiography access can take up to 12 months in some regions. That delay is not a cardiology problem — it lands in your practice as a missed diagnosis, a worsened outcome, and a documentation liability.

Internal medicine practitioners who act as cardiac gatekeepers without diagnostic tools are taking on clinical and financial risk with no upside. The infrastructure to close that gap — FDA-cleared, reimbursable, and validated at ACC.26 — exists right now.

Internal medicine is no longer just the front door to cardiac care — it is the diagnosis room, the documentation room, and the revenue room, all at once. According to Doctronic, primary care providers can already manage approximately 80% of cardiovascular conditions — which means the infrastructure gap is not clinical capability, it is diagnostic tooling and coding discipline.

The Heart Failure Society of America has flagged another compounding risk: inconsistent HF coding practices that fail to recognize heart failure as a primary underlying cause are actively suppressing HCC capture across Medicare Advantage panels. That is not a compliance footnote — it is revenue walking out the door on every claim.

The case for acting now comes down to three converging pressures:

• Policy mandate: UnitedHealthcare's 2026 referral-before-cardiology rule makes point-of-care cardiac evaluation operationally non-negotiable
• Clinical stakes: The Lancet and Scandinavian Journal data confirm that hospital-first heart failure diagnosis carries dramatically worse mortality outcomes
• Revenue compliance: RADV audits now cover all ~550 eligible Medicare Advantage contracts annually, with zero tolerance for unsupported HCC codes

Practices that close these gaps with in-office cardiac diagnostics and AI-powered HCC accuracy are not just improving care — they are protecting revenue and reducing audit exposure simultaneously.

Ready to close your cardiac care gap? Visit Perfect Rhythm to explore solutions for your practice today.

Frequently Asked Questions

What does closing cardiac care gaps in internal medicine mean?

It means identifying and diagnosing cardiovascular conditions — including CAD, pulmonary hypertension, and heart failure — at the point of primary care rather than waiting for hospital presentation or specialist referral. According to PMC research, heart failure is the leading cause of hospitalization in internal medicine settings, making early in-office detection both a clinical and financial priority.

How does point-of-care cardiac diagnostics compare to hospital referral for patient outcomes?

The outcomes difference is significant. A study published in the Scandinavian Journal of Primary Health Care found one-year all-cause mortality of 42% for hospital-diagnosed heart failure patients versus 20% for those diagnosed in primary care. Earlier detection in the office, not the ER, saves lives.

What is the CorVista System and how is it used in internal medicine?

CorVista is an FDA-cleared, AI-powered diagnostic system that detects coronary artery disease, pulmonary hypertension, and heart failure without radiation, injections, contrast agents, or fasting. It is designed for use directly in an internal medicine office, producing results with 88% sensitivity and a 99% negative predictive value for CAD — comparable to coronary CT angiography for ruling out significant disease.

Why does the UnitedHealthcare 2026 referral policy matter to internal medicine practices?

Effective January 1, 2026, UnitedHealthcare requires all HMO and HMO-POS Medicare Advantage members to obtain a PCP referral before seeing a cardiologist, with claim denials beginning May 1, 2026. According to Cardiovascular Business, this formally positions the internal medicine physician as the mandatory cardiac gatekeeper for millions of Medicare Advantage enrollees.

How do RADV audits affect internal medicine practices with Medicare Advantage patients?

CMS now audits all approximately 550 eligible Medicare Advantage contracts annually, and every unsupported HCC code is treated as a 100% overpayment under the 2023 RADV Final Rule. Practices without airtight HCC documentation — particularly under the V28 model, which removed 2,294 diagnosis codes — face significant compliance and revenue exposure that AI-assisted coding tools are specifically designed to address.